InsidersTradesSigma
维康药业 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 维康药业 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 维康药业 has recorded 2 reports. Market capitalisation: €3.7bn. The latest transaction was disclosed on 1 November 2022 (Sale). Among the most active insiders: 戴德雄. The full history is free.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
1 ops.
Sell Volume
12Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,899 of 25,567 companies
29.5
score / 100
Value30
Quality29
FCF yld-0.0%
Earn yld-4.8%
EV/EBITDA·
ROE-21%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 November 2022